USAHKPD▲
Cellyan Biotechnology Receives Nasdaq Extension to Regain Minimum Bid Price Compliance
Cellyan Biotechnology Co., Ltd has been granted an additional 180-day grace period by Nasdaq to regain compliance with the minimum $1.00 closing bid price requirement. The company received a notification letter on July 14, 2026, extending the deadline to January 11, 2027. To meet the requirement, Cellyan's Class A ordinary shares must close at or above $1.00 for at least ten consecutive business days before that date. The company stated it will coordinate feasible compliance solutions, including a possible reverse share split, though there is no assurance of success. The notification has no immediate effect on the listing, and shares continue to trade under the ticker HKPD.